Statement of the AGNP-Work Group “Child and Adolescent Pharmacology” on the Decision of the Joint Federal Committee (GBA) of the 17/02/2011 to Combine Escitalopram with Citalopram into a Fixed Amount Group

doi:10.1055/s-0032-1311601

Pharmacopsychiatry, Inhaltsverzeichnis

Pharmacopsychiatry 2012; 45(03): III
DOI: 10.1055/s-0032-1311601

AGNP News

Statement of the AGNP-Work Group “Child and Adolescent Pharmacology” on the Decision of the Joint Federal Committee (GBA) of the 17/02/2011 to Combine Escitalopram with Citalopram into a Fixed Amount Group

Abstract

Volltext

Referenzen

References
1 Carandang C, Jabbal R, MacBride A et al. A review of Escitalopram and Citalopram in Child and Adolescent Depression. J Can Acad Child Adolesc Psychiatry 2011; 20: 315-324
2 Cipriani A, Furukawa TA, Salanti G et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet online Jan 29 2009; 1-13
3 Emslie GJ, Ventura D, Korotzer A et al. Escitalporam in the treatment of Adolescent Depression: A randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry 2009; 48,7: 721-729
4 Holsboer-Trachsler E, Baumann P, Höck P et al. Escitalopram in der klinischen Praxis. Psychopharmakotherapie 2011; 18,2: 59-65
5 Jensen PS, Hinshaw SPO, Kraemer HC et al. ADHD comorbidity findings from the MTA study: comparing comorbid soubgroups. J Am Acad Child Adolesc Psychiatry 2001; 40,2: 147-158
6 von Knorring AL, Olsson GI, Thomsen PH et al. A randomized, double-blind, pacebocontrolled study of citalopram in adolescents with major depressive disorder. J Clin Psychopharmocol 2007; 26,3: 311-315
7 Kuguya A, Seneca NM, Snyder PJ et al. Changes in human in vivo serotonine and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology 2003; 28: 413-420
8 Moore N, Verdoux H, Fantino B. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. Int Clin Psychopharmacol 2005; 20: 131-137
9 Taurines R, Schmitt J, Renner T et al. Developmental comorbidity in attention deficit-/hyperactivity disorder. Atten Defic Hyperact Disord 2010; 2,4: 267-289
10 Trkulja. Is Escitalopram really relevantly superior to Citalopram in treatment of major depressive disorder? A meta-analysis of head-to-head randomized trials. Clinical Sciences 2010;
11 Wagner KD, Robb AS, Findling RL et al. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 2004; 161,6: 1079-1083
12 Wagner KD, Jonas J, Findling RL et al. A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 2006; 45,3: 280-288
13 Yang LPH, Scott LJ. Escitalopram in the treatment of major depressive disorder in adolescent patients. Pediatr Drugs 2010; 12,3: 155-163
14 Yevtushenko VY, Belous AI, Yevtushenko YG et al. Efficacy and tolerability of Escitalopram versus Citalopram in major depressive disorder: A 6 week multicenter, prospective, randomized, double blind, active controlled study in adult outpatients. Clin Ther 2007; 29, 11: 2319-2332